The clinical utility and adverse consequences of the complete blood count in an internal medicine department.


Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
07 2019
Historique:
received: 12 06 2018
revised: 04 02 2019
accepted: 28 04 2019
entrez: 12 7 2019
pubmed: 12 7 2019
medline: 15 2 2020
Statut: ppublish

Résumé

The clinical utility and adverse consequences of the admission and follow-up complete blood count (CBC) in hospitalised patients are unclear. We selected 273 patients chosen from a single internal medicine department. To determine clinical utility and adverse consequences, we interviewed attending physicians and reviewed patients' charts. There were 12 (4.4%) patients hospitalised because of the CBC test result, six referred appropriately with a low haemoglobin concentration found in outpatient clinics and six (2.2%) patients (95% confidence interval 0.8-4.7%) inappropriately hospitalised because of incidental findings. In the hospital, according to the physicians, nearly all treatment changes made were for blood transfusions that were not indicated in 18 (6.6%) patients (95% confidence interval 4.0-10.2%). The only unexpected findings were in four patients with an indication for a blood transfusion admitted with an acute coronary syndrome and haemoglobin values 8-9.9 g/dL, and in one bedridden patient with dementia with acute myeloid leukaemia. There were 290 follow-up CBC tests not resulting in differential treatment. We conclude that admission CBC tests commonly lead to adverse consequences, due to physician errors in judgement. Incidental findings of anaemia justify CBC testing in patients with an acute coronary event. The rare patient with an incidental finding resulting in appropriate differential treatment might justify non-selective admission CBC counts, if physician education reduces the rate of inappropriate blood transfusions.

Identifiants

pubmed: 31295773
doi: 10.1111/imj.14353
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

915-918

Informations de copyright

© 2019 Royal Australasian College of Physicians.

Auteurs

Zvi Shimoni (Z)

Department of Internal Medicine B, Sanz Medical Center, Laniado Hospital, Netanya, Israel.
Ruth and Bruce Rappaport School of Medicine, Haifa, Israel.

Leeor Amit (L)

Ruth and Bruce Rappaport School of Medicine, Haifa, Israel.

Michal Rosenberg (M)

Ruth and Bruce Rappaport School of Medicine, Haifa, Israel.

Paul Froom (P)

Department of Clinical Utility, Sanz Medical Center, Laniado Hospital, Netanya, Israel.
School of Public Health, University of Tel Aviv, Tel Aviv-Yafo, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH